These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 17439965)

  • 21. Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles.
    Kwekkeboom RF; Sluijter JP; van Middelaar BJ; Metz CH; Brans MA; Kamp O; Paulus WJ; Musters RJ
    J Control Release; 2016 Jan; 222():18-31. PubMed ID: 26616760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay.
    Behm-Ansmant I; Rehwinkel J; Izaurralde E
    Cold Spring Harb Symp Quant Biol; 2006; 71():523-30. PubMed ID: 17381335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro optimization of 2'-OMe-4'-thioribonucleoside-modified anti-microRNA oligonucleotides and its targeting delivery to mouse liver using a liposomal nanoparticle.
    Takahashi M; Yamada N; Hatakeyama H; Murata M; Sato Y; Minakawa N; Harashima H; Matsuda A
    Nucleic Acids Res; 2013 Dec; 41(22):10659-67. PubMed ID: 24030710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNA and shRNA expression vectors based on mRNA and miRNA processing.
    Wu P; Wilmarth MA; Zhang F; Du G
    Methods Mol Biol; 2013; 936():195-207. PubMed ID: 23007510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Illuminating miRNA Inhibition: Visualizing the Interaction between Anti-miRNA Oligonucleotide and Target miRNA Using FRET.
    Zhu H; Kamiya Y; Asanuma H
    ACS Chem Biol; 2023 Oct; 18(10):2281-2289. PubMed ID: 37789826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA.
    Suryawanshi H; Sarangdhar MA; Vij M; Roshan R; Singh VP; Ganguli M; Pillai B
    J Vis Exp; 2015 Dec; (106):e53307. PubMed ID: 26779762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo.
    Su YL; Swiderski P; Marcucci G; Kortylewski M
    Methods Mol Biol; 2019; 1974():141-150. PubMed ID: 31099000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current perspectives in intronic micro RNAs (miRNAs).
    Ying SY; Lin SL
    J Biomed Sci; 2006 Jan; 13(1):5-15. PubMed ID: 16228283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
    Kaucsár T; Rácz Z; Hamar P
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs: novel regulators in cardiac development and disease.
    Thum T; Catalucci D; Bauersachs J
    Cardiovasc Res; 2008 Sep; 79(4):562-70. PubMed ID: 18511432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene silencing in vitro and in vivo using intronic microRNAs.
    Lin SL; Ying SY
    Methods Mol Biol; 2006; 342():295-312. PubMed ID: 16957384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.
    Mehta M; Satija S; Paudel KR; Malyla V; Kannaujiya VK; Chellappan DK; Bebawy M; Hansbro PM; Wich PR; Dua K
    Nanomedicine; 2021 Jan; 31():102303. PubMed ID: 32980549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing activity of 2'-O-methyl modified anti-MDR1 siRNAs with mismatches in the central part of the duplexes.
    Petrova NS; Meschaninova MI; Venyaminova AG; Zenkova MA; Vlassov VV; Chernolovskaya EL
    FEBS Lett; 2011 Jul; 585(14):2352-6. PubMed ID: 21704032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs.
    Hamada M; Ohtsuka T; Kawaida R; Koizumi M; Morita K; Furukawa H; Imanishi T; Miyagishi M; Taira K
    Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):301-9. PubMed ID: 12477280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting of microRNAs for therapeutics.
    Stenvang J; Lindow M; Kauppinen S
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1197-200. PubMed ID: 19021524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to antagonize miRNA functions in vitro and in vivo.
    Baigude H; Rana TM
    Nanomedicine (Lond); 2014 Nov; 9(16):2545-55. PubMed ID: 25490425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
    Stenvang J; Silahtaroglu AN; Lindow M; Elmen J; Kauppinen S
    Semin Cancer Biol; 2008 Apr; 18(2):89-102. PubMed ID: 18295505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pSM155 and pSM30 vectors for miRNA and shRNA expression.
    Wu J; Bonsra AN; Du G
    Methods Mol Biol; 2009; 487():205-19. PubMed ID: 19301649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model.
    Lee ST; Chu K; Jung KH; Kim JH; Huh JY; Yoon H; Park DK; Lim JY; Kim JM; Jeon D; Ryu H; Lee SK; Kim M; Roh JK
    Ann Neurol; 2012 Aug; 72(2):269-77. PubMed ID: 22926857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intron-mediated RNA interference, intronic microRNAs, and applications.
    Ying SY; Chang CP; Lin SL
    Methods Mol Biol; 2010; 629():205-37. PubMed ID: 20387152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.